Company Overview

Aflac Incorporated is a U.S.-based insurance holding company that provides supplemental health and life insurance products. The company operates primarily in the supplemental insurance industry, offering policies that pay cash benefits directly to policyholders to help cover expenses not typically reimbursed by primary health insurance. Aflac’s core revenue drivers are premium income and investment income generated from its insurance operations.

The company serves individuals, families, and employers, with a strong focus on payroll-deducted insurance products sold through the workplace. Aflac’s strategic advantage lies in its strong brand recognition—particularly in the United States—its leading market position in Japan’s supplemental insurance market, and its long-standing expertise in underwriting and claims management. Founded in 1955 by the Amos family, Aflac began as a small insurance provider and expanded significantly over decades, establishing international operations in Japan in the 1970s, which became a central pillar of its growth.

Business Operations

Aflac operates through two primary business segments: Aflac Japan and Aflac U.S.. Aflac Japan is the company’s largest segment by revenue and earnings, offering cancer insurance, medical insurance, and life insurance products to individuals through independent agencies, corporate partnerships, and bancassurance channels. Aflac U.S. focuses on supplemental insurance products such as accident, cancer, critical illness, hospital indemnity, and short-term disability, primarily distributed through employers.

The company generates revenue mainly from insurance premiums and investment income derived from its large, conservatively managed investment portfolio. Aflac maintains significant insurance reserves and controls proprietary underwriting, policy administration, and claims-processing systems. Its operations are supported by subsidiaries including Aflac Japan Insurance Co., Ltd. and American Family Life Assurance Company of Columbus, which underwrite policies in their respective markets.

Strategic Position & Investments

Aflac’s strategic direction emphasizes disciplined growth in its core U.S. and Japanese markets, digital transformation of policy administration and claims processing, and capital efficiency. The company has invested heavily in technology to streamline enrollment, enhance customer experience, and improve data analytics across underwriting and risk management functions.

The company also pursues targeted investments through Aflac Corporate Ventures, which focuses on emerging technologies in insurtech, healthcare services, and workforce benefits. While Aflac has not pursued large-scale transformative acquisitions in recent years, it has made minority investments and strategic partnerships aimed at enhancing distribution capabilities, automation, and health-related service offerings that complement its supplemental insurance portfolio.

Geographic Footprint

Aflac’s operations are concentrated in Japan and the United States, with Japan representing the majority of total revenue and profits. The company is headquartered in Columbus, Georgia, United States, and maintains significant operational infrastructure, sales networks, and partnerships across both countries.

While Aflac does not operate insurance underwriting businesses outside these two core markets, it has global investment exposure through its investment portfolio and maintains a presence in international capital markets. Its influence in Japan is particularly significant, where it is one of the leading providers of cancer and medical insurance products and maintains deep relationships with financial institutions and corporate partners.

Leadership & Governance

Aflac is led by an executive team with long tenures in insurance and financial services, emphasizing conservative risk management, policyholder protection, and shareholder returns. The company’s leadership philosophy focuses on long-term value creation, strong capital discipline, and maintaining trust with policyholders and distribution partners.

Key executives include:

• Daniel P. Amos – Chairman of the Board
• Daniel P. Amos – Former Chief Executive Officer
• Frederick J. Crawford – Chief Executive Officer
• Maxwell K. Brodén – Chief Financial Officer
• Audrey B. Tillman – Executive Vice President and General Counsel
• Virgilio S. Perez – President, Aflac U.S.
• Masatoshi Koide – President, Aflac Japan

The board and management team oversee corporate governance in alignment with regulatory requirements in both the U.S. and Japan, with a strong emphasis on compliance, financial transparency, and risk oversight.